Veriheal

OCTOBER 1, 2020

Cannabis is easily accessible, and the regulations are loosening up quite a bit. In 2018, the government was confronted by a media storm that has called for them to act. The media storm came about as 12-year-old Billy Caldwell and 6-year-old Alfie Dingley were being denied cannabis oil as a treatment for their epilepsy.

Legalization 104

Legalization Medicine Oil Media 104

Canna Law Blog

APRIL 13, 2019

The letters were sent “in response to their making unsubstantiated claims related to more than a dozen different products and spanning multiple product webpages, online stores and social media websites.” Specifically, the agency fears that.

CBD 96

CBD Safety Topical Food 96

Veriheal

MARCH 1, 2022

The campaign manager of the ‘Yes on 109’ campaign that helped see the measure passed, Sam Chapman, told media sources, “There’s a huge breadth of expertise on this board from harm reduction experts to folks that have experience working with different populations that stand to benefit from having access to psilocybin therapy.

Therapy 98

Therapy Programs Microdosing Medicine 98

MMJ Recs

FEBRUARY 29, 2024

The landscape of medical marijuana has evolved, offering patients alternative avenues for accessing therapeutic cannabis. Florida allows qualified patients to access medical marijuana, but home cultivation is generally not permitted. The state mandates strict THC potency limits in medical cannabis products, emphasizing patient safety.

Cultivation 52

Cultivation Marijuana Environment Patients 52

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. Leadership hires in clinical science, regulatory affairs, clinical safety, quality and manufacturing, in preparation for phase III, new compounds and additional indications.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

APRIL 13, 2022

Securing a Dealer’s License to accompany its existing research exemptions would cement Delic Labs’ position as the leader in psychedelic safety testing. The Company aims to establish consistent quality control standards as more patients and clinicians incorporate psychedelic compounds into treatment plans.

Research and Development 52

Research and Development Treatment Extraction Medicine 52

Cannabis Law Report

JULY 24, 2021

This expansive patent would allow Mydecine to scale its coverage in drug development research in lieu of promising discoveries and FDA-approval progress for novel therapeutics, including granting Breakthrough Therapy Designation to MDMA for the treatment of PTSD in recent years. For more information, please contact: Media Contacts.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Cannabis Law Report

MAY 6, 2022

The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. In short, the FDA has not evaluated or logged all dangerous side effects or safety concerns. Delta-8 is known to be successful in many cancer treatments.”.

THC 52

THC CBD Media Food 52

Cannabis Law Report

AUGUST 21, 2019

Cannabis treatments are too expensive and do not come with enough test evidence to be effective, UK authorities have said. It also said current treatments for adults suffering severe symptoms were “not cost effective”. This would answer questions about safety and efficacy, they said. AUTHOR: Mark Taylor.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Cannabis Law Report

MAY 26, 2022

So we need to discuss openly and critically how we can remain balanced and ensure the potential of psychedelics can be optimised without compromising safety.”. And how do we make sure treatments are safe, accessible, and inclusive? Learn more about ICPR 2022 by connecting on social media using the #ICPR2022 hashtag.

Research and Development 52

Research and Development Therapy Policy Media 52

Cannabis Law Report

NOVEMBER 22, 2019

MMJ will be utilizing its new products for an FDA approved treatment of multiple sclerosis (MS) and Huntington’s disease (HD). “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. . “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”.

DEA 66

DEA Clinical Trials THC Research and Development 66

Veriheal

MAY 17, 2021

Other states have gone beyond just medical access and have also legalized retail cannabis markets for adult consumers. Theodore happens to also be an addiction expert who refuses to provide treatment to patients that choose to consume cannabis as he believes it interferes with the treatment of other addictions.

Legalization 86

Legalization Pharmaceutical Therapy Chronic Pain 86

SpeedWeed

JUNE 9, 2021

Those companies operating under the license type are required to comply with customer verification processes and safety regulations detailed by the CCC. “I We know that it’s very lucrative, but for Jenny and I, a lot of this is really based on access, and delivery is the best way to bring access to folks.”.

Safety 40

Safety Access Cannabis Programs 40

Cannabis Law Report

FEBRUARY 28, 2022

Importantly, control of psychedelics by a small number of companies may stifle innovation and reduce access to these therapies. 1025, 1026 (2021) (reporting significant improvement of PTSD symptoms following treatment with MDMA in clinical trial); see also Alec J. Mitchell et al., Divito & Robert F. 11 × 11. TIMES (Nov.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

The Cannigma

JULY 1, 2022

What if most of it is not based on the level of scientific certainty that cannabis marketing teams and media outlets would have us believe? Preclinical studies involve exposing cells and animals to treatments to see if there are indications that the treatment could be worth evaluating in humans. The cannabis research problem.

Research and Development 112

Research and Development Data THC Clinical Trials 112

MMJ Recs

JULY 3, 2024

From the pressures of work and personal relationships to the constant bombardment of information on social media and the news, many individuals find themselves struggling to cope with these challenges. One potential and alternative treatment for anxiety and stress has emerged over the years.

CBD 52

CBD Research and Development Clinical Trials THC 52

Greenspoon Marder Cannabis Law Group Blog

APRIL 2, 2019

For example, we’re seeking comments, data and information on a variety of topics including: what levels of cannabis and cannabis-derived compounds cause safety concerns; how the mode of delivery (e.g., For Alzheimer’s patients, CBD is one treatment option that is slowing the progression of that disease.”.

CBD 40

CBD Research and Development Safety Therapy 40

Cannabis Law Report

JANUARY 13, 2020

commercial and government payors to ensure that appropriate patients have access to Epidiolex with as few restrictions as possible. Additional pipeline: Commence Phase 2b study of a cannabidiol formulation for the treatment of schizophrenia. Media Enquiries: Sam Brown Inc. media enquiries. Work with U.S. Christy Curran.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

SEPTEMBER 24, 2019

Some parents, who have travelled to the Netherlands to buy cannabis medicines, feel the treatment will not help many children because it does not contain THC, which they argue has helped their children. These treatments can be prescribed only by specialist doctors in a limited number of circumstances where other medicines have failed.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

CannaMD

MARCH 19, 2020

As Florida’s leading medical cannabis physicians , CannaMD is committed to working closely with licensed dispensaries to ensure medical cannabis patients stay safe while continuing uninterrupted treatment during the coronavirus (COVID-19) crisis. As always, we remain committed to your safety, and look forward to continuing to serve you.

Policy 90

Policy Dispensary Patients Safety 90

Cannabis Law Report

JULY 20, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. Ability to meet the overall health needs of qualified patients and safety of the public. Health and safety standards for lab employees. Criterion 7. 20 pts .

Law 40

Law Marijuana Education Cultivation 40

The Joint Blog

JUNE 19, 2023

This growth is fueled by the increasing acceptance of CBD as a natural and safe alternative to traditional veterinary treatments, as well as the growing body of research supporting its use in managing various health conditions in animals.

Pets 29

Pets CBD Research and Development Safety 29

Cannabis Law Report

DECEMBER 14, 2021

“Columbia Care’s mission has always been to provide patients with access to the highest quality, safest medicinal cannabis products available. We are proud to leverage our proprietary IP, formulation expertise, safety surveillance and patient reported data from the U.S. Media Lindsay Wilson. media@col-care.com.

Extraction 52

Extraction Patients Medicine Tincture 52

Alchimia

JANUARY 4, 2016

The three most populated Australian States (Victoria, New South Wales, Queensland) promised to organize studies on the efficiency of cannabis to alleviate terminally ill patients, controlling severe epilepsy in children, as well as for the treatment of side effects of chemotherapy. But on August 17, 2015 a judge has authorized Graciela?s

Marijuana 48

Marijuana Epilepsy Pharmaceutical Chronic Pain 48

SpeedWeed

MARCH 5, 2021

Several factors are in play, according to union officials and labor experts: The pandemic increased employee anxiety and concerns about workplace health and safety, opening the window for union organizing. In Massachusetts, workers at a New England Treatment Access (NETA) dispensary in Brookline soundly rejected the union by a 30-9 vote.

Marijuana 52

Marijuana Dispensary Retail Business 52

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Accessed July 25, 2021. Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. This article analyses media representations of medicinal cannabis in Australian medical publications. Background.

Research and Development 52

Research and Development Medicine Access Media 52

CannaMD

MARCH 8, 2021

1455 covers three major themes: medical marijuana advertising, THC potency/access to high-THC products, and administrative issues. Prohibiting a medical marijuana treatment center from dispensing marijuana that exceeds a certain potency of tetrahydrocannabinol [p. Food & Drug Association’s role in H.B. Florida H.B.

THC 116

THC Research and Development Treatment Patients 116

The Cannigma

MARCH 2, 2022

Hear the tale of how Anthony came to work in the cannabis space, telling the stories of cannabis brands and making them accessible to non-users. Anthony is the founder of the Trav Media Group. We’ve got a segment with Americans for Safe Access, talking a little bit about regulation and some current affairs. This is a pleasure.

Wellness and Beauty 52

Wellness and Beauty Cannabis Media Patients 52

SpeedWeed

JULY 19, 2021

On June 23, Canada’s cannabis regulatory agency, Health Canada, released a private document requested under the Access to Information Act (AIA), that country’s version of the US government’s Freedom of Information Act. The document in question was a 2020 safety study of the vape cartridge additive phytol. Courtesy University of Utah).

Vaping 52

Vaping Terpenes Data Research and Development 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

OCTOBER 4, 2021

As a result, the TGA had not evaluated these products for quality, safety or efficacy and the manufacturer had not obtained relevant approvals. The TGA alleges that the individual also made a prohibited representation , on a related social media platform, in relation to the use of CBD oil for the treatment of cancer.

Law 52

Law Treatment Medicine CBD 52

Cannabis Law Report

JULY 15, 2022

Sunshine Coast based Tikun Oceana, formerly known as Medifarm , is now under the control of administrators from Cor Cordis.The company was founded …… Predictably Murdoch media has this behind a paywall if you want to pay to learn more. But bottlenecks remain to doctors prescribing the controversial treatment.

Medicine 52

Medicine Patients Media Supply Chain 52

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access.

Patients 87

Patients Compliance Compliance Cannabis 87

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. Our proprietary ranking system takes into account: Social reach (social media, blogs, podcasts, publications, etc.). Through his social media outlets, podcast, blog, and interviews, Tim has educated hundreds of millions of people about psychedelics. Followers.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

MAY 30, 2021

Lansing City Pulse reports… A graphic circulating on social media encourages customers to boycott several cannabis brands affiliated with the Michigan Cannabis Manufacturers Association. Their products also don’t have to be tested at a safety compliance laboratory. They aren’t doing that for patient access. KYLE KAMINSKI.

Patients 105

Patients Cannabis Retail Legislation 105

Cannabis Law Report

JANUARY 21, 2019

Track-and-Trace System Reporting Requirements, Section 40513 Track-and-Trace – Loss of Access, Section 40515 Track-and-Trace Temporary Licenses, and Section 40517 Track-and-Trace System – UID Tag Order. All electronic storage systems must provide a complete and accurate record of your data that is accessible to the IRS. .

Seed-To-Sale 40

Seed-To-Sale Business Compliance Compliance 40